Nicholas Willumsen Selected Research

Nicholas Willumsen Research Topics

Disease

36	Neoplasms (Cancer) 04/2024 - 01/2013
13	Fibrosis (Cirrhosis) 10/2023 - 02/2019
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2017
6	Adenocarcinoma 01/2024 - 01/2021
6	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 05/2017
5	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 11/2013
4	Breast Neoplasms (Breast Cancer) 08/2021 - 01/2013
4	Melanoma (Melanoma, Malignant) 10/2020 - 10/2014
4	Carcinogenesis 12/2019 - 02/2019
3	Inflammation (Inflammations) 01/2023 - 04/2011
3	Chronic Obstructive Pulmonary Disease (COPD) 11/2019 - 10/2014
3	Lung Neoplasms (Lung Cancer) 02/2019 - 10/2014
3	Idiopathic Pulmonary Fibrosis 08/2016 - 10/2014
2	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2020
2	Rheumatoid Arthritis 04/2023 - 12/2022
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020 - 01/2018
2	Ulcerative Colitis 01/2020 - 01/2018
2	Hypersensitivity (Allergy) 09/2012 - 04/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2023
1	Chronic Pancreatitis 01/2023
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2023
1	Heart Failure 09/2021
1	Disease Progression 08/2021
1	Triple Negative Breast Neoplasms 08/2021
1	Anastomotic Leak 02/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	Crohn Disease (Crohn's Disease) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Inguinal Hernia (Direct Inguinal Hernia) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Pathologic Processes 11/2019

Drug/Important Bio-Agent (IBA)

35	Biomarkers (Surrogate Marker)IBA 02/2024 - 11/2013
29	CollagenIBA 01/2024 - 01/2018
11	Collagen Type III (Type III Collagen)IBA 02/2024 - 05/2017
10	Complement C3 (C3 Complement)IBA 10/2023 - 01/2020
9	Matrix Metalloproteinases (MMPs)IBA 12/2022 - 10/2014
8	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2013
7	VimentinIBA 10/2020 - 10/2014
5	Collagen Type I (Type I Collagen)IBA 01/2023 - 10/2014
4	Peptides (Polypeptides)IBA 01/2024 - 01/2020
4	Immune Checkpoint InhibitorsIBA 10/2021 - 12/2018
4	Collagen Type IV (Type IV Collagen)IBA 09/2020 - 01/2016
3	Collagen Type VIIBA 01/2020 - 03/2019
3	Metalloproteases (Metalloproteinases)IBA 05/2019 - 05/2017
3	ElastinIBA 02/2019 - 10/2014
2	Bevacizumab (Avastin)FDA Link 10/2023 - 01/2021
2	Complement C5 (Complement 5)IBA 01/2023 - 01/2020
2	Collagen Type V (Type V Collagen)IBA 01/2023 - 01/2020
2	Fibrillar CollagensIBA 11/2022 - 03/2019
2	Peptide Hydrolases (Proteases)FDA Link 02/2022 - 02/2019
2	IpilimumabIBA 09/2020 - 12/2018
2	Tumor Biomarkers (Tumor Markers)IBA 06/2020 - 05/2019
2	EpitopesIBA 01/2020 - 05/2019
2	Collagen Type VIIIIBA 01/2019 - 08/2016
1	Protons (Proton)IBA 04/2024
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 04/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 04/2024
1	RNA (Ribonucleic Acid)IBA 01/2024
1	Collagen Type XVIIIBA 10/2023
1	Immunodominant EpitopesIBA 04/2023
1	AutoantibodiesIBA 04/2023
1	C-Reactive ProteinIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Mannose ReceptorIBA 02/2022
1	Plasma KallikreinIBA 01/2022
1	tetrathiomolybdate (ammonium tetrathiomolybdate)IBA 08/2021
1	CopperIBA 08/2021
1	Collagen Type XIIBA 01/2021
1	3-(2'-pyridyldithio)benzyldiazoacetate (MPDA)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	PEGPH20IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 10/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2020
1	Granzymes (Granzyme)IBA 09/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	Procollagen Type IIBA 01/2020
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020
1	Arginine (L-Arginine)FDA Link 01/2020
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	ZincIBA 01/2020
1	Lapatinib (GW572016)FDA Link 08/2019
1	Docetaxel (Taxotere)FDA Link 08/2019
1	Trastuzumab (Herceptin)FDA Link 08/2019
1	Leukocyte Elastase (Neutrophil Elastase)IBA 02/2019
1	Cathepsin GIBA 02/2019
1	Myeloblastin (Proteinase 3)IBA 02/2019
1	vastatinIBA 01/2019
1	type IV collagen alpha3 chain (Goodpasture antigen)IBA 04/2018
1	Conditioned Culture MediaIBA 05/2017
1	N-acetyltalosaminuronic acid (NAT)IBA 05/2017
1	TrypsinIBA 05/2017

Therapy/Procedure

4	Therapeutics 02/2024 - 01/2013
3	Immunotherapy 01/2023 - 09/2012
2	Drug Therapy (Chemotherapy) 10/2023 - 01/2021
1	Herniorrhaphy 01/2020
1	Neoadjuvant Therapy 08/2019
1	Precision Medicine 01/2018